Glenview Capital Management
North America, New York, United States, New York
Description
Glenview Capital Management is a hedge fund founded in 2000 with approximately $9.2 billion of capital under management.
Investor Profile
Glenview Capital Management has backed more than 9 startups, with 1 new investments in the last 12 months alone. The firm has led 4 rounds, about 44% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series D, Series B rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Health Care, Medical, Medical Device.
- Led 1 rounds in the past year.
Stage Focus
- Post Ipo Equity (33%)
- Series D (22%)
- Series B (11%)
- Series C (11%)
- Series A (11%)
- Series E (11%)
Country Focus
- United States (78%)
- United Kingdom (22%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Health Care
- Medical
- Medical Device
- Clinical Trials
- Manufacturing
- Personal Health
- Biotechnology
- Health Diagnostics
- Life Science
- Energy
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
